Skip to main content
| News

The DayOne Accelerator, in its 3rd year, is now accepting applications

02.10.2020

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

If you are a digital health entrepreneur that wants to gain feedback on your innovation, build connections across the healthcare ecosystem and potentially win a place in the DayOne Accelerator, then you are in the right place.  The accelerator will again help you to develop your digital health venture together with one of Europe’s leading ecosystems with coaching, space and potential funding. The first step to send in your application before the 23.10.20 deadline. We will let you know by 05.11.2020 whether you are shortlisted for the accelerator program and therefore invited to in the DayOne Open Innovation Session

This year the accelerator will have three categories: Patient Centric Innovation, Diabetes & Metabolism, and Value Based Healthcare. For more information about the categories, full list of winner benefits, list of previous winners and more, visit the DayOne Accelerator page.

Don’t forget to apply before the 23.10.20 deadline, and feel free to send those in your network who could also be interested in participating;  after all, we do love collaboration at DayOne.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 60

Do you have a question? We'd like to hear from you.